Novanta Inc. NOVT R2KR3KTECH

Q: What is the current share price of Novanta Inc. (NOVT)?

As of 2026-10-23 16:27 PDT, Novanta Inc. (NOVT) trades at $140.80 on NasdaqGS. Its 52-week range is $99.22 to $168.75.

Q: What is the market capitalisation of NOVT?

Novanta Inc. (NOVT) has a market capitalisation of $5.32B on NasdaqGS.

Q: What is the P/E ratio of NOVT?

NOVT trades at a trailing price-to-earnings (P/E) ratio of 89.11. The industry average P/E is 30.29. Its price-to-book (P/B) ratio is 3.11.

Q: What is the return on equity (ROE) of NOVT?

NOVT has a return on equity (ROE) of 5.11%. Its return on capital employed (ROCE) is 5.90%.

Q: Is NOVT a good stock to buy?

This page provides a data-driven analysis of Novanta Inc. (NOVT), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Technology · Scientific & Technical Instruments · United States

https://www.novanta.com

Company Profile ↓

$140.80

+12.76% 1Y

Mkt Cap$5.32B

P/E89.11

P/B3.11

52W High$168.75

52W Low$99.22

Book Value$42.74

EPS (TTM)$1.58

Company Overview

Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles. This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; imaging, identification and RFID solutions; advanced motion control solutions; and light engines, and integrated operating room technologies. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is based in Bedford, Massachusetts.

Why Investors Should Care

Conservative Balance Sheet

Carries low leverage with a debt-to-equity ratio of 0.18.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

Dec 2025 Revenue of $980.60M (+3.3% YoY); net profit $53.83M.
Trailing 12 Months Year-on-year growth — revenue +10.3%, earnings +150.0%.
5-Year Trend Long-term compounding — revenue CAGR 8.8%, profit CAGR 3.9%.

Growth & Price Performance

Compounded Sales Growth

5 Years:	8.80%
1 Year:	10.30%

Compounded Profit Growth

5 Years:	3.87%
1 Year:	150.00%

Stock Price Performance

1 Year:	+12.76%
6 Months:	+5.00%
3 Months:	+0.00%
1 Month:	-0.52%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bearish

52-Week Range 60% of range

$99.22 $168.75

Trend Signals

Price vs 50-DMABelow
Price vs 200-DMABelow
RSI (14)50.30 · Neutral

Price Performance

1M-0.52%

3M+0.00%

6M+5.00%

1Y+12.76%

Valuation vs Sector

P/E of 89.11 is above the sector median of 30.29 — pricier than peers.

Auto-generated from price history and fundamentals; not investment advice.

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Period: Metric:

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

Generates positive free cash flow.
In a confirmed uptrend (50-DMA above 200-DMA).

CONS

Trading at a high P/E of 89.1.

* The pros and cons are auto-generated from financial metrics.

Valuation

Stock P/E

89.11

Industry PE

30.29

Forward P/E

32.24

PEG Ratio

Book Value

$42.74

Price to Book

3.11

P/S

4.89

EV/EBITDA

25.41

Dividend Yield

0.00%

Growth (CAGR)

Revenue 5Y

8.80%

Profit 5Y

3.87%

Revenue (YoY)

10.30%

Earnings (YoY)

150.00%

Profitability & Returns

ROCE

5.90%

ROE

5.11%

ROA

4.09%

Profit Margin

6.00%

Op Margin

11.50%

Gross Margin

44.54%

EPS (Latest Qtr)

$0.30

EPS (TTM)

$1.58

Balance Sheet & Liquidity

Debt/Equity

0.18

Quick Ratio

3.65

Current Ratio

4.57

Debt

$285.60M

Total Assets

$2.14B

Current Assets

Working Capital

Ownership

Promoter Holding

0.71%

Chg in Prom Hold

-0.04%

FII / Inst Holding

123.50%

Chg in FII Hold

-0.09%

Financial Snapshot

Enterprise Value

$5.32B

Total Revenue (TTM)

$1.03B

EBITDA

$180.95M

Free Cash Flow

$118.38M

Operating Cash Flow

$133.84M

Shares Outstanding

37.82M

Gross Margin

44.54%

Payout Ratio

0.00%

Peer comparison

Peer companies in the same sector (Technology).

#	Name	CMP $	P/E	Mkt Cap	Div Yld %	ROCE %	ROE %	Rev CAGR 5Y %	Profit CAGR 5Y %
1	NOVT Novanta Inc. R2KR3KTECH	140.80	89.11	$5.32B	0.00%	5.90%	5.11%	8.80%	3.87%
2	NVDA NVIDIA Corporation NDXSPXR3KAITECH	210.96	26.64	$5.09T	0.46%	74.66%	117.21%	24.64%	32.12%
3	AAPL Apple Inc. NDXSPXR3KTECH	347.72	39.88	$5.07T	0.32%	68.72%	148.75%	1.81%	3.92%
4	MSFT Microsoft Corporation NDXSPXR3KAITECH	524.51	29.19	$3.89T	0.79%	26.33%	34.04%	9.93%	11.90%
5	TSM Taiwan Semiconductor Manufacturing Company Limited AITECH	418.51	31.19	$2.17T	0.95%	30.20%	39.97%	18.94%	19.57%
6	AVGO Broadcom Inc. NDXSPXR3KAITECH	321.68	41.08	$1.54T	0.72%	16.70%	44.25%	17.04%	54.08%
7	MU Micron Technology, Inc. NDXSPXR3KAITECH	877.55	19.82	$991.10B	0.05%	13.69%	66.64%	13.68%	26.02%
8	AMD Advanced Micro Devices, Inc. NDXSPXR3KAITECH	516.79	131.83	$843.65B	0.00%	5.47%	10.20%	11.81%	66.28%
9	ASML ASML Holding N.V. NDXAITECH	1,571.80	51.02	$603.73B	0.50%	42.97%	53.94%	15.55%	19.55%

Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric	Mar 2014	Jun 2014	Sep 2014	Dec 2014	Apr 2015	Jul 2015	Oct 2015	Dec 2015	Apr 2016	Jul 2016	Sep 2016	Mar 2017	Jun 2017	Sep 2017	Mar 2018	Jun 2018	Sep 2018	Mar 2019	Jun 2019	Sep 2019	Apr 2020	Jul 2020	Oct 2020	Apr 2021	Jul 2021	Oct 2021	Apr 2022	Jul 2022	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Apr 2026	Jul 2026
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	119.10M	146.30M	146.97M	150.40M	160.79M	157.19M	155.15M	154.07M	155.47M	144.73M	142.93M	162.58M	167.52M	177.73M	204.22M	215.36M	222.96M	219.13M	229.46M	221.50M	230.92M	235.86M	244.41M	233.37M	241.05M	247.84M	257.71M	265.81M
Gross Profit	32.10M	38.65M	39.68M	39.73M	40.01M	41.34M	39.91M	36.63M	36.89M	41.50M	41.21M	46.09M	53.49M	58.71M	62.16M	65.23M	69.63M	66.29M	65.78M	64.05M	64.44M	58.70M	59.10M	68.74M	72.41M	76.30M	90.28M	95.25M	98.41M	97.63M	104.12M	101.59M	100.42M	103.69M	109.22M	104.35M	106.75M	110.92M	113.58M	120.92M
Operating Income	4.07M	6.48M	6.82M	-34.18M	5.40M	10.31M	9.01M	4.21M	2.59M	7.60M	11.05M	10.34M	15.75M	12.41M	17.23M	17.11M	21.00M	14.39M	15.11M	12.80M	13.25M	13.70M	11.87M	11.10M	15.99M	15.28M	24.28M	23.29M	28.66M	26.31M	32.20M	30.31M	25.61M	25.71M	32.55M	32.42M	14.91M	21.85M	27.54M	18.06M
Net Income	983.00K	725.00K	4.53M	-30.48M	3.45M	19.50M	6.57M	-	1.91M	4.87M	7.47M	34.25M	9.40M	7.53M	11.91M	11.00M	14.55M	12.25M	10.38M	8.92M	11.95M	11.66M	8.26M	11.31M	11.66M	13.60M	18.82M	17.48M	22.49M	18.27M	20.88M	21.22M	14.68M	13.76M	19.19M	21.21M	4.50M	10.65M	21.10M	12.54M
Diluted EPS	0.03	0.02	0.13	-0.88	0.10	0.56	0.19	0.18	0.05	0.14	0.21	0.98	0.16	0.00	0.18	0.32	0.60	0.35	0.29	0.25	0.34	0.33	0.23	0.32	0.33	0.38	0.53	0.49	0.63	0.51	0.58	0.59	0.41	0.38	0.53	0.59	0.12	0.30	0.51	0.30
R&D Expense	5.86M	7.53M	7.74M	7.84M	8.21M	7.84M	7.69M	7.29M	8.05M	8.02M	7.96M	9.21M	9.00M	11.66M	11.99M	12.55M	13.20M	14.00M	13.39M	13.81M	15.33M	14.44M	15.23M	18.68M	16.95M	17.47M	20.93M	21.59M	21.35M	22.83M	23.38M	22.02M	23.25M	23.73M	23.25M	23.24M	25.29M	24.09M	23.25M	23.97M

Profit & Loss (Annual)

Figures in USD.

Metric	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue	254.39M	285.89M	304.30M	243.80M	316.91M	364.71M	373.60M	384.76M	521.29M	614.34M	626.10M	590.62M	706.79M	860.90M	881.66M	949.25M	980.60M
Gross Profit	98.55M	130.61M	133.10M	105.52M	132.23M	150.17M	157.89M	162.45M	220.53M	261.53M	262.08M	244.52M	300.33M	378.47M	399.90M	421.55M	435.28M
Operating Income	-20.24M	36.03M	35.85M	20.26M	19.45M	-16.81M	28.93M	32.95M	57.57M	71.01M	55.28M	55.89M	64.05M	103.08M	110.50M	110.58M	94.01M
Net Income	-71.33M	-687.00K	28.97M	19.54M	7.31M	-24.25M	35.62M	22.00M	60.05M	49.11M	40.77M	44.52M	50.33M	74.05M	72.88M	64.09M	53.83M
Diluted EPS	-4.48	-0.03	0.86	0.58	0.21	-0.70	1.02	0.63	1.13	1.43	1.15	1.25	1.41	2.06	2.02	1.77	1.47
R&D Expense	28.25M	22.30M	23.45M	18.53M	23.79M	28.95M	31.04M	32.00M	41.67M	51.02M	55.97M	61.00M	72.52M	85.77M	91.68M	95.52M	95.48M

Balance Sheet (Annual)

Figures in USD.

Metric	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Assets	-	-	367.17M	348.50M	337.46M	378.81M	396.29M	416.05M	425.64M	726.70M	719.58M	869.74M	865.18M	1.23B	1.24B	1.23B	1.39B	1.81B
Total Equity	152.90M	84.31M	178.35M	209.00M	227.81M	241.98M	210.82M	244.70M	258.87M	311.55M	368.25M	417.17M	476.81M	521.29M	577.59M	673.46M	745.70M	1.31B
Cash & Equivalents	69.00M	63.33M	56.78M	54.84M	65.79M	60.98M	51.15M	59.96M	68.11M	100.06M	82.04M	78.94M	125.05M	117.39M	100.11M	105.05M	113.99M	380.87M
Long Term Debt	-	-	107.58M	58.00M	42.50M	64.00M	105.03M	88.43M	70.55M	225.50M	202.84M	215.33M	194.93M	429.36M	430.66M	349.40M	411.95M	212.54M
Total Liabilities	-	-	188.49M	139.14M	109.25M	136.40M	185.04M	171.34M	166.77M	368.24M	351.32M	452.56M	388.37M	706.59M	663.63M	552.60M	642.81M	492.82M
Current Liabilities	-	-	59.26M	59.06M	54.93M	61.49M	54.06M	56.95M	70.50M	98.17M	104.20M	134.85M	114.23M	183.94M	164.52M	139.18M	167.79M	212.37M

Cash Flows (Annual)

Figures in USD.

Metric	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Operating Cash Flow	-25.79M	-4.74M	45.17M	28.43M	49.20M	42.29M	33.42M	47.79M	63.38M	89.65M	63.25M	140.24M	94.62M	90.78M	120.08M	158.51M	64.06M
Investing Cash Flow	19.71M	8.75M	-4.22M	2.98M	-72.96M	-89.77M	-1.63M	-12.87M	-177.38M	-45.59M	-63.84M	-13.16M	-306.70M	-42.54M	-19.89M	-208.19M	-74.32M
Financing Cash Flow	-	-11.56M	-43.09M	-21.11M	18.57M	40.28M	-21.54M	-23.19M	143.33M	-60.16M	-3.94M	-84.36M	204.75M	-60.15M	-97.85M	56.94M	276.33M
Capital Expenditure	-1.32M	-2.66M	-4.22M	-3.52M	-4.78M	-5.42M	-5.55M	-8.46M	-9.09M	-14.66M	-10.74M	-10.52M	-19.98M	-19.64M	-19.96M	-17.16M	-15.63M
Free Cash Flow	-27.11M	-7.40M	40.96M	24.91M	44.42M	36.87M	27.86M	39.33M	54.28M	74.99M	52.51M	129.72M	74.65M	71.14M	100.11M	141.35M	48.43M
Share Buybacks	-	-	-	-	526.00K	-	1.63M	1.63M	370.00K	5.85M	10.00M	5.50M	-	10.00M	-	-	39.28M

Ratios (Annual)

Figures in %.

Metric	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Gross Margin %	38.7%	45.7%	43.7%	43.3%	41.7%	41.2%	42.3%	42.2%	42.3%	42.6%	41.9%	41.4%	42.5%	44.0%	45.4%	44.4%	44.4%
Operating Margin %	-8.0%	12.6%	11.8%	8.3%	6.1%	-4.6%	7.7%	8.6%	11.0%	11.6%	8.8%	9.5%	9.1%	12.0%	12.5%	11.6%	9.6%
Net Margin %	-28.0%	-0.2%	9.5%	8.0%	2.3%	-6.6%	9.5%	5.7%	11.5%	8.0%	6.5%	7.5%	7.1%	8.6%	8.3%	6.8%	5.5%
ROE %	-84.6%	-0.4%	13.9%	8.6%	3.0%	-11.5%	14.6%	8.5%	19.3%	13.3%	9.8%	9.3%	9.7%	12.8%	10.8%	8.6%	4.1%
ROCE %	-	11.7%	12.4%	7.2%	6.1%	-4.9%	8.1%	9.3%	9.2%	11.5%	7.5%	7.4%	6.1%	9.6%	10.2%	9.1%	5.9%

Shareholding Pattern

Insiders

0.71%

Institutions

123.50%

Public Float

124.38%

Top Institutional Holders

#	Holder	% Held	Shares	Value
1	Blackrock Inc.	12.69%	4.80M	$677.87M
2	Vanguard Portfolio Management LLC	6.33%	2.40M	$338.46M
3	Price (T.Rowe) Associates Inc	5.88%	2.22M	$313.99M
4	Allspring Global Investments Holdings, LLC	4.81%	1.82M	$256.79M
5	Vanguard Capital Management LLC	4.25%	1.61M	$227.03M
6	State Street Corporation	3.80%	1.44M	$202.99M
7	Conestoga Capital Advisors, LLC	3.22%	1.22M	$172.07M
8	Geode Capital Management, LLC	2.61%	987.73K	$139.55M
9	Congress Asset Management Co	2.59%	979.84K	$138.43M
10	GW&K Investment Management, LLC	2.37%	897.27K	$126.77M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for NOVT

Google News hu, 22 Oct 2026

Novanta Inc. (NOVT) Stock Price, News, Quote & History - Yahoo! Finance Canada

<a href="https://news.google.com/rss/articles/CBMiUkFVX3lxTE80b1EwY2s4Z2hyamI2NzVWQWxwT0RwNkphaFVwdDRfSTVBcDZ2cUpEWUVIY2kwQ25ZOVZyRzZXblo3bDh0VjJ1LXVpZ2czQkdDbnc?oc=5" target="_blank">Novanta Inc. (NOVT) Stock Price, News, Quote & History</…

Google News Fri, 23 Oct 2026

Novanta Inc. Estimates – NASDAQ:NOVT - TradingView

<a href="https://news.google.com/rss/articles/CBMieEFVX3lxTE9zazAzWEZsdTdGWWpQUC1uekNGR3lBdm9UUGNYOU1VRVJTQk5jSG9ZcTNhTlZ5VG5pQnhsZV92VEYwWjMtMEZUMjlxeXQ4eG8tNGZnSFdSRFdVblpUTk0zNmZoRW5FU0Njd3NfeUFsY3ZRbG5DeV9qaQ?oc=5" target="_blank">Novan…

Google News Wed, 21 Oct 2026

Novanta Inc. (NOVT) stock price, news, quote and history - Yahoo Finance Singapore

<a href="https://news.google.com/rss/articles/CBMiUkFVX3lxTFA0REZLRzlHaGpzZUd5aG1lRlZVS1dmZ0Q2NUlRZWlEclFNbTV2dEY4RV9XR1dRVzNHcmFOQ093N3JDWmhvMUV4emhoQVViUDRIMWc?oc=5" target="_blank">Novanta Inc. (NOVT) stock price, news, quote and history…

Google News Wed, 21 Oct 2026

Novanta Inc (NOVT) Stock Up 3.2% and Still Undervalued -- GF Sco - GuruFocus

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxQMmtWa3d4QldhYVhKbG1TU1ROM0Nva1JuNTU4TTV6QmlfSHNrUzZhNlZGMFR4cG9GOE5RUTNjVThOSXNpTDBfbjFLME1vSVhodTlUZzBRTDNWRkhpSHRpODBoT212MjRLbGQ0VHdMd3ZJSjlBNExlUUd2SlBBM1gybUFMTS1DOTZWdUtFdU…

Google News ue, 20 Oct 2026

Novanta's finance chief and medical-solutions chief are scheduled to speak in Chicago Nov. 11. - Stock Titan

<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxPTjRfalJibTlFM2F3d25BcnBVVEYyOHVGeDZRR1puZVV1bTZTbzNhbE9zOTB1dXJHaWFKOXdhRjVCdXlPdWdmMnlUSmRVVVdCZnc5bU5mcllCS1ZsZjd1VHZBSXJXSVZCT21pZXhrRm01c3k5RkVfU2EtcVVzem9lbGJlalc5Q0V1SG5WdT…

Google News Fri, 23 Oct 2026

Trading Systems Reacting to (NOVT) Volatility - Stock Traders Daily

<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxPZEFvWXF2UnhORlBVOEs1NEwxLU5aNUt0bGdPQkd3Z1ZWeFdKSmhIVnJNNUVndW5DNmJMaXgzQm9wc19jSEdEV2djb3dId1JiS016NlZtd002aDJTMUVJN0VoTzJuakVSZXY5cVlTRkZrU0xIM3Q1Mnp0aGh6aXh4ZjRNUWNiVkNHanVacU…

NOVT — Frequently Asked Questions

What is the current share price of Novanta Inc. (NOVT)?

As of 2026-10-23 16:27 PDT, Novanta Inc. (NOVT) trades at $140.80 on NasdaqGS. Its 52-week range is $99.22 to $168.75.

What is the market capitalisation of NOVT?

Novanta Inc. (NOVT) has a market capitalisation of $5.32B on NasdaqGS.

What is the P/E ratio of NOVT?

NOVT trades at a trailing price-to-earnings (P/E) ratio of 89.11. The industry average P/E is 30.29. Its price-to-book (P/B) ratio is 3.11.

What is the return on equity (ROE) of NOVT?

NOVT has a return on equity (ROE) of 5.11%. Its return on capital employed (ROCE) is 5.90%.

Is NOVT a good stock to buy?

This page provides a data-driven analysis of Novanta Inc. (NOVT), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Technology Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks

Novanta Inc. NOVT R2KR3KTECH

Company Overview

Why Investors Should Care

Recent Developments

Growth & Price Performance

Compounded Sales Growth

Compounded Profit Growth

Stock Price Performance

Price Chart

Technical Trend

Fundamental Growth Charts

PROS

CONS

Valuation

Growth (CAGR)

Profitability & Returns

Balance Sheet & Liquidity

Ownership

Financial Snapshot

Peer comparison

Quarterly Results

Profit & Loss (Annual)

Balance Sheet (Annual)

Cash Flows (Annual)

Ratios (Annual)

Shareholding Pattern

Top Institutional Holders

Analyst View

Latest News

Novanta Inc. (NOVT) Stock Price, News, Quote & History - Yahoo! Finance Canada

Novanta Inc. Estimates – NASDAQ:NOVT - TradingView

Novanta Inc. (NOVT) stock price, news, quote and history - Yahoo Finance Singapore

Novanta Inc (NOVT) Stock Up 3.2% and Still Undervalued -- GF Sco - GuruFocus

Novanta's finance chief and medical-solutions chief are scheduled to speak in Chicago Nov. 11. - Stock Titan

Trading Systems Reacting to (NOVT) Volatility - Stock Traders Daily

NOVT — Frequently Asked Questions

What is the current share price of Novanta Inc. (NOVT)?

What is the market capitalisation of NOVT?

What is the P/E ratio of NOVT?

What is the return on equity (ROE) of NOVT?

Is NOVT a good stock to buy?

Explore More